Basic Information
Adoram Therapeutics is a developer of allosteric modulators aimed at providing an effective target for cancer immunotherapy. The company's modulators assist in treating solid tumors based on small-molecule immunotherapy, overcoming the limitations of previous generations of drugs in adenosine-rich tumors, enabling researchers to address unmet medical needs in the field of tumor immunology.